Chemotherapy
Overview
Chemotherapy is a peer-reviewed medical journal that focuses on the latest advancements in the field of cancer treatment. It publishes original research articles, reviews, and clinical studies, covering various aspects of chemotherapy, including drug development, mechanisms of action, resistance, and novel therapeutic approaches. The journal serves as a valuable resource for oncologists, pharmacologists, and researchers, providing insights into the evolving landscape of chemotherapy and its impact on patient care.
Details
Details
Abbr.
Chemotherapy
Start
1968
End
Continuing
Frequency
Bimonthly
p-ISSN
0009-3157
e-ISSN
1421-9794
Country
Switzerland
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 6023
61
SJR / Ranks: 6738
663
CiteScore / Ranks: 4133
5.70
JIF / Ranks: 3040
3.3
Recent Articles
1.
Wang L, Yang K, Xie X, Wei H, Wang P, Wang S
Chemotherapy
. 2025 Mar;
:1-24.
PMID: 40081340
Introduction: To evaluate the efficacy and safety of cryoablation combined with pembrolizumab treatment versus cryoablation alone in patients with advanced non-small cell lung cancer (NSCLC). Methods: This retrospective study was...
2.
Murata D, Azuma K, Nishii Y, Murotani K, Matama G, Kawahara A, et al.
Chemotherapy
. 2025 Jan;
:1-7.
PMID: 39842417
Introduction: Identifying the underlying mechanisms of immune checkpoint inhibitor resistance in patients with cachexia is a current challenge. Ghrelin is a peptide hormone that plays an important role in the...
3.
Harano T, Ikeda M, Hirano S, Shimura S, Toyoda M, Okuda S, et al.
Chemotherapy
. 2025 Jan;
1-7.
PMID: 39748616
Introduction: Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) therapy is indicated as first-line or neoadjuvant chemotherapy (NAC) for patients with advanced or metastatic urothelial carcinoma (UC). However, no studies reported...
4.
Maximova N, Calabro P, Cangialosi A, Di Paolo A
Chemotherapy
. 2024 Dec;
1-10.
PMID: 39694022
Introduction: High-dose methotrexate (MTX) is used to treat pediatric acute lymphoblastic leukemia (ALL). The drug has a low therapeutic index and a highly interindividual variability in systemic exposure. These characteristics...
5.
Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani M
Chemotherapy
. 2024 Dec;
1-12.
PMID: 39631371
Introduction: This study investigates the efficacy of fucoidan combination with antibiotics, against single-species biofilms and mixed-species, individual planktonic, and coculture planktonic conditions of Methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii...
6.
Guo C, Yang Q, Xi S, Zhou J, Zhou Z, Cao X, et al.
Chemotherapy
. 2024 Nov;
:1-11.
PMID: 39557019
Introduction: We report the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of a multi-kinase inhibitor (TG02 capsule) as a new therapy for patients with recurrent high-grade gliomas in China. Methods:...
7.
Hui Y, Ke F, Lu W, Qiu W, Zheng X, Cheng H
Chemotherapy
. 2024 Nov;
:1-7.
PMID: 39527937
Introduction: Duodenal squamous cell carcinoma is an exceedingly rare occurrence among gastrointestinal malignancies, and its diagnosis and treatment are not well understood. Case Presentation: In this report, we present a...
8.
Ferrari V, Morand L, Hyvernat H, Schiappa R, Dellamonica J, Martis N
Chemotherapy
. 2024 Nov;
:1-9.
PMID: 39522504
Introduction: Our study aimed to identify relevant features associated with the reprisal of antineoplastic treatment in patients with solid cancers after unplanned admittance to the intensive care unit (ICU) and...
9.
Seydoux C, Briki M, Wagner A, Choong E, Guidi M, Carrara S, et al.
Chemotherapy
. 2024 Nov;
:1-10.
PMID: 39510060
Background: Despite major advances in cancer treatment in the past years, there is a need to optimize chemotherapeutic drug dosing strategies to reduce toxicities, suboptimal responses, and the risk of...
10.
Branda F, Ceccarelli G, Giovanetti M, Ciccozzi M, Scarpa F
Chemotherapy
. 2024 Oct;
70(1):9-11.
PMID: 39401492
No abstract available.